NO141407C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivaterInfo
- Publication number
- NO141407C NO141407C NO741815A NO741815A NO141407C NO 141407 C NO141407 C NO 141407C NO 741815 A NO741815 A NO 741815A NO 741815 A NO741815 A NO 741815A NO 141407 C NO141407 C NO 141407C
- Authority
- NO
- Norway
- Prior art keywords
- ethylender
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2356873A GB1421792A (en) | 1973-05-17 | 1973-05-17 | Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO741815L NO741815L (no) | 1974-11-19 |
| NO141407B NO141407B (no) | 1979-11-26 |
| NO141407C true NO141407C (no) | 1980-03-05 |
Family
ID=10197791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO741815A NO141407C (no) | 1973-05-17 | 1974-05-16 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US3953460A (no) |
| JP (1) | JPS5040560A (no) |
| AR (1) | AR213262A1 (no) |
| AT (1) | AT334362B (no) |
| BE (1) | BE814941A (no) |
| BG (1) | BG25786A3 (no) |
| CA (1) | CA1050551A (no) |
| CS (1) | CS185654B2 (no) |
| DD (1) | DD113896A5 (no) |
| DE (1) | DE2423813A1 (no) |
| ES (1) | ES426405A1 (no) |
| FI (1) | FI151974A (no) |
| FR (1) | FR2229417B1 (no) |
| GB (1) | GB1421792A (no) |
| HU (1) | HU172300B (no) |
| IE (1) | IE39435B1 (no) |
| IL (1) | IL44752A (no) |
| IN (1) | IN141252B (no) |
| LU (1) | LU70104A1 (no) |
| MW (1) | MW1774A1 (no) |
| NL (1) | NL7406660A (no) |
| NO (1) | NO141407C (no) |
| PH (1) | PH11040A (no) |
| PL (1) | PL102353B1 (no) |
| RO (1) | RO69780A (no) |
| SE (1) | SE416049B (no) |
| SU (1) | SU537625A3 (no) |
| ZA (1) | ZA742650B (no) |
| ZM (1) | ZM7374A1 (no) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1554153A (en) * | 1975-05-15 | 1979-10-17 | Smith Kline French Lab | Process for making 2-amino-2-alkylthionitroethylenes |
| US4192879A (en) * | 1975-05-21 | 1980-03-11 | Smith Kline & French Laboratories Limited | Imidazolyl alkylamino nitroethylene compounds |
| IL49528A (en) * | 1975-05-21 | 1980-11-30 | Smith Kline French Lab | Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them |
| GB1564502A (en) | 1975-07-31 | 1980-04-10 | Smith Kline French Lab | Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives |
| US4169855A (en) * | 1976-08-04 | 1979-10-02 | Allen & Hansbury, Limited | N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine |
| GB1565966A (en) | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| IE47044B1 (en) | 1977-04-20 | 1983-12-14 | Ici Ltd | Guanidine derivatives |
| US4165378A (en) | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
| US4153704A (en) * | 1977-05-16 | 1979-05-08 | Smith Kline & French Laboratories Limited | Ethylene derivatives |
| IE46886B1 (en) * | 1977-05-17 | 1983-10-19 | Allen & Hanburys Ltd | Aminoalkyl-benzene derivatives |
| GB1601459A (en) * | 1977-05-17 | 1981-10-28 | Allen & Hanburys Ltd | Aminoalkyl thiophene derivatives |
| US4233302A (en) | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
| EP0006679B1 (en) | 1978-05-24 | 1982-07-21 | Imperial Chemical Industries Plc | Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them |
| ZA792608B (en) * | 1978-05-30 | 1980-06-25 | Smith Kline French Lab | Nitro compounds |
| US4584384A (en) * | 1978-05-30 | 1986-04-22 | Smith Kline & French Laboratories Limited | Nitro pyrroles |
| IL57415A (en) * | 1978-05-30 | 1984-08-31 | Smith Kline French Lab | Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them |
| US4200760A (en) * | 1978-09-26 | 1980-04-29 | Bristol-Myers Company | Imidazolylalkylthioalkylamino-ethylene derivatives |
| US4221737A (en) | 1978-09-26 | 1980-09-09 | Bristol-Myers Company | 1-(Alkynyl)amino-1-(mercaptoalkyl)amino ethylenes |
| US4282363A (en) * | 1978-11-24 | 1981-08-04 | Bristol-Myers Company | 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives |
| US4250316A (en) * | 1978-11-24 | 1981-02-10 | Bristol-Myers Company | Pyridyl guanidine anti-ulcer agents |
| US4289876A (en) * | 1978-11-24 | 1981-09-15 | Bristol-Myers Company | Antisecretory agents |
| US4200578A (en) | 1978-12-18 | 1980-04-29 | Bristol-Myers Company | Thiazole derivatives |
| NL8000869A (nl) * | 1979-02-16 | 1980-08-19 | Eisai Co Ltd | Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan. |
| US4220654A (en) * | 1979-06-04 | 1980-09-02 | Merck & Co., Inc. | Cyclic imidazole cyanoguanidines |
| FI803127L (fi) * | 1979-10-03 | 1981-04-04 | Glaxo Group Ltd | Heterocykliska foereningar |
| US4382090A (en) * | 1980-10-02 | 1983-05-03 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds |
| US4375547A (en) * | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
| US4525477A (en) * | 1981-12-02 | 1985-06-25 | Smith Kline & French Laboratories Limited | 2-Thiazolyl, isothiazolyl, oxazolyl and isoxazolyl alkylamino-3-nitro-heterocyclic compounds |
| NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
| DE3232462A1 (de) * | 1982-09-01 | 1984-03-01 | Bayer Ag, 5090 Leverkusen | 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| AU2222083A (en) * | 1982-12-14 | 1984-06-21 | Smith Kline & French Laboratories Limited | Pyridine derivatives |
| DE3546858C2 (de) * | 1984-06-15 | 1995-04-20 | Glaxo Group Ltd | Verfahren zur Herstellung von Ranitidin |
| GB8415254D0 (en) * | 1984-06-15 | 1984-07-18 | Glaxo Group Ltd | Amine derivatives |
| JPH085859B2 (ja) * | 1986-07-01 | 1996-01-24 | 日本バイエルアグロケム株式会社 | 新規アルキレンジアミン類 |
| EP0285681B1 (de) * | 1987-04-06 | 1993-03-10 | HEUMANN PHARMA GMBH & CO | Verfahren zur Herstellung von Nitroethenderivaten |
| WO1998005317A1 (en) * | 1996-08-06 | 1998-02-12 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| KR20010012326A (ko) * | 1997-05-07 | 2001-02-15 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 치환 3,3-디아미노-2-프로펜니트릴, 그것의 제조방법 및사용 |
| US5955548A (en) * | 1997-05-07 | 1999-09-21 | Novo Nordisk A/S | Substituted 3, 3-diamino-2-propenenitriles, their preparation and use |
| GB2344588B (en) * | 1997-07-25 | 2001-11-14 | Black James Foundation | 1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands |
| GB9715814D0 (en) | 1997-07-25 | 1997-10-01 | Black James Foundation | Histamine H3 receptor ligands |
| KR100302348B1 (ko) * | 1999-04-24 | 2001-09-22 | 류덕희 | 니자티딘의 제조방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1078569A (en) * | 1962-12-06 | 1967-08-09 | Gen Aniline & Film Corp | Improvements in or relating to cyanoethylene compounds |
| US3404159A (en) * | 1966-12-19 | 1968-10-01 | Gaf Corp | Bis hetero methylene malononitriles |
| BE758146A (fr) * | 1969-10-29 | 1971-04-28 | Smith Kline French Lab | Derives de l'amidine |
| US3808336A (en) * | 1970-06-25 | 1974-04-30 | Smithkline Corp | Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives |
| US3734924A (en) * | 1970-10-14 | 1973-05-22 | Smith Kline French Lab | Carboxamidines |
| US3905984A (en) * | 1971-03-09 | 1975-09-16 | Smith Kline French Lab | Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas |
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| GB1397436A (en) * | 1972-09-05 | 1975-06-11 | Smith Kline French Lab | Heterocyclic n-cyanoguinidines |
-
1973
- 1973-05-17 GB GB2356873A patent/GB1421792A/en not_active Expired
-
1974
- 1974-04-23 IN IN916/CAL/74A patent/IN141252B/en unknown
- 1974-04-25 ZA ZA00742650A patent/ZA742650B/xx unknown
- 1974-04-30 MW MW17/74*UA patent/MW1774A1/xx unknown
- 1974-05-02 IL IL44752A patent/IL44752A/xx unknown
- 1974-05-06 ZM ZM73/74A patent/ZM7374A1/xx unknown
- 1974-05-06 PL PL1974171110A patent/PL102353B1/pl unknown
- 1974-05-09 US US05/468,617 patent/US3953460A/en not_active Expired - Lifetime
- 1974-05-10 PH PH15821A patent/PH11040A/en unknown
- 1974-05-13 BE BE144247A patent/BE814941A/xx not_active IP Right Cessation
- 1974-05-13 AT AT392974A patent/AT334362B/de not_active IP Right Cessation
- 1974-05-15 SE SE7406472A patent/SE416049B/sv not_active IP Right Cessation
- 1974-05-15 CS CS7400003473A patent/CS185654B2/cs unknown
- 1974-05-15 DD DD178521A patent/DD113896A5/xx unknown
- 1974-05-16 FI FI1519/74A patent/FI151974A/fi unknown
- 1974-05-16 CA CA200,137A patent/CA1050551A/en not_active Expired
- 1974-05-16 DE DE2423813A patent/DE2423813A1/de not_active Withdrawn
- 1974-05-16 JP JP49055300A patent/JPS5040560A/ja active Pending
- 1974-05-16 LU LU70104A patent/LU70104A1/xx unknown
- 1974-05-16 SU SU2025129A patent/SU537625A3/ru active
- 1974-05-16 NO NO741815A patent/NO141407C/no unknown
- 1974-05-16 HU HU74SI00001406A patent/HU172300B/hu unknown
- 1974-05-17 BG BG026720A patent/BG25786A3/xx unknown
- 1974-05-17 NL NL7406660A patent/NL7406660A/xx not_active Application Discontinuation
- 1974-05-17 AR AR253803A patent/AR213262A1/es active
- 1974-05-17 FR FR7417347A patent/FR2229417B1/fr not_active Expired
- 1974-05-17 IE IE1052/74A patent/IE39435B1/xx unknown
- 1974-05-17 ES ES426405A patent/ES426405A1/es not_active Expired
- 1974-05-17 RO RO7478828A patent/RO69780A/ro unknown
-
1980
- 1980-02-04 US US06/117,903 patent/US4284640A/en not_active Expired - Lifetime
- 1980-02-04 US US06/117,901 patent/US4317829A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| NO144885C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO142304C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater | |
| NO145576C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater | |
| NO145883C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater | |
| NO149281C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater | |
| NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
| NO145791C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
| NO140597C (no) | Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater | |
| NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
| NO142303C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater | |
| NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
| NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| NO142260C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater | |
| NO141161C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater | |
| NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
| NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
| NO143664C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive dibenzofuranforbindelser | |
| NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
| NO141441C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on | |
| NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
| NO141341C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivat | |
| NO142669C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser | |
| NO146672C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater |